Trial Details

Not Recruiting
Basic Information
Clinical ID c5561
Identifier NL-OMON27672
Trial Title Adjusting infliximab dose in IBD patients in remission, based on infliximab trough levels: the study on Infliximab Levels in IBD patients Steering Treatment, the ILIST pilot
Trial URL Visit Original Page
Study Information
Study Results

NULL
Conditions Inflammatory Bowel Disease, in remission with infliximab treatment.
Interventions IFX trough levels are measured in IBD patients in long term remission. Based on IFX trough levels, the IFX dose may be adjusted. The IFX dosing interval does not change.<br />If IFX trough levels are high (<3mg/mL), the IFX dose is reduced to 3mg/kg i
Participant Information
Sponsor Erasmus MC Rotterdam
City NULL
Country/Region NULL
Enrollment Criteria
Sex Requirement NOT SPECIFIED
Age Requirement NULL
Study Design
Study Type Interventional
Phase NULL
Time Information
Start Date NULL
Primary Completion Date NULL
Completion Date NULL